Nanjing Well Pharmaceutical Co.,Ltd.’s Net Profit Dropped 1.6% in First Three Quarters of 2023

Nanjing Well Pharmaceutical Co.,Ltd. (南京威尔药业集团股份有限公司) (603351.SH) reported a net profit of 76 million yuan in the first three quarters of 2023, down 1.6% year-on-year.

Meanwhile, the company posted 828.7 million yuan in revenue, down 2.6% year-on-year.

At the end of the reporting period, it had 2.3 billion yuan in total assets and 732.7 million yuan in total liabilities, with a liability-to-asset ratio of 32%.